What is the share price of Quick Heal Technologies Ltd (QUICKHEAL) today?
The share price of QUICKHEAL as on 5th June 2026 is ₹180.01. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Quick Heal Technologies Ltd (QUICKHEAL) share?
The past returns of Quick Heal Technologies Ltd (QUICKHEAL) share are- Past 1 week: -5.99%
- Past 1 month: 6.54%
- Past 3 months: 17.34%
- Past 6 months: -37.88%
- Past 1 year: -48.37%
- Past 3 years: 23.30%
- Past 5 years: -21.05%
What are the peers or stocks similar to Quick Heal Technologies Ltd (QUICKHEAL)?
The peers or stocks similar to Quick Heal Technologies Ltd (QUICKHEAL) include:What is the market cap of Quick Heal Technologies Ltd (QUICKHEAL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Quick Heal Technologies Ltd (QUICKHEAL) is ₹976.52 Cr as of 5th June 2026.What is the 52 week high and low of Quick Heal Technologies Ltd (QUICKHEAL) share?
The 52-week high of Quick Heal Technologies Ltd (QUICKHEAL) is ₹416.70 and the 52-week low is ₹125.What is the PE and PB ratio of Quick Heal Technologies Ltd (QUICKHEAL) stock?
The P/E (price-to-earnings) ratio of Quick Heal Technologies Ltd (QUICKHEAL) is -89.34. The P/B (price-to-book) ratio is 2.21.Which sector does Quick Heal Technologies Ltd (QUICKHEAL) belong to?
Quick Heal Technologies Ltd (QUICKHEAL) belongs to the Information Technology sector & IT Services & Consulting sub-sector.How to buy Quick Heal Technologies Ltd (QUICKHEAL) shares?
You can directly buy Quick Heal Technologies Ltd (QUICKHEAL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Quick Heal Technologies Ltd
QUICKHEAL Share Price
NSEQUICKHEAL Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
QUICKHEAL Performance & Key Metrics
QUICKHEAL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -89.34 | 2.21 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 21.62 | 5.83 | 3.21% |
QUICKHEAL Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
QUICKHEAL Company Profile
Quick Heal Technologies Limited provides information technology security solutions.
QUICKHEAL Sentiment Analysis
QUICKHEAL Sentiment Analysis
QUICKHEAL Stock Summary · May 2026
Management framed the quarter as a strategic inflection point: amid the company’s weakest quarterly profitability and FY26 revenue declining to Rs. 261 crore, leadership is accelerating a deliberate pivot from a consumer antivirus vendor to an integrated enterprise and government cybersecurity provider, targeting enterprise revenues to rise to roughly 80–90% of the top line within 2–3 years. The tone was resolute about sustained investment—R&D and sales & marketing remain prioritized while the product set has been expanded with EDR, XDR, data‑privacy, digital risk protection and ransomware‑recovery services and AI/ML embedded across detection, classification and response; operational threat research and growing cloud deployments were positioned as competitive supports. Management acknowledged clear tension: enterprise and regulatory contract momentum is offsetting consumer weakness and channel headwinds, and tighter credit controls have pressured near‑term top line and receivables. They emphasized a debt‑free balance sheet and intent to continue funding the transformation without drastic cost cuts, expecting enterprise contract traction to drive recovery toward their stated multi‑year targets.
QUICKHEAL Stock Growth Drivers
QUICKHEAL Stock Growth Drivers
7Strategic Repositioning to a Full‑Spectrum Cybersecurity Provider
The company has executed a deliberate transformation from a B2C antivirus vendor into a broad
Enterprise Revenue Momentum and Structural Mix Shift
The enterprise vertical has scaled significantly—from roughly 20% of revenue five years ago to over
QUICKHEAL Stock Challenges
QUICKHEAL Stock Challenges
6Severe Deterioration in Financial Performance
The company has moved from roughly Rs.100 crores of annual profit historically to reporting a
Persistent Consumer-Vertical Weakness and Industry Headwinds
The consumer antivirus business is undergoing secular degrowth and consolidation, producing sustained revenue weakness that
QUICKHEAL Forecast
QUICKHEAL Forecasts
QUICKHEAL
QUICKHEAL
Income
Balance Sheet
Cash Flow
QUICKHEAL Income Statement
QUICKHEAL Income Statement
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 86.07 | 86.85 | 75.35 | 78.69 | 75.52 | 70.74 | 62.98 | 87.90 | 80.49 | 52.48 | ||||||||||
| Operating & Other expenses | 70.30 | 69.99 | 67.70 | 70.42 | 74.38 | 73.62 | 66.96 | 74.29 | 71.09 | 78.05 | ||||||||||
| EBITDA | 15.77 | 16.86 | 7.65 | 8.27 | 1.14 | -2.88 | -3.98 | 13.61 | 9.40 | -25.57 | ||||||||||
| Depreciation/Amortization | 3.24 | 3.18 | 2.79 | 3.15 | 3.39 | 3.63 | 2.96 | 3.28 | 3.59 | 4.07 | ||||||||||
| PBIT | 12.53 | 13.68 | 4.86 | 5.12 | -2.25 | -6.51 | -6.94 | 10.33 | 5.81 | -29.64 | ||||||||||
| Interest & Other Items | 0.00 | 0.13 | 0.05 | 0.05 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 | 0.03 | ||||||||||
| PBT | 12.53 | 13.55 | 4.81 | 5.07 | -2.31 | -6.57 | -7.00 | 10.28 | 5.75 | -29.67 | ||||||||||
| Taxes & Other Items | 2.47 | -0.49 | 0.78 | 0.92 | -2.42 | -3.32 | -1.49 | 2.37 | -0.86 | -9.73 | ||||||||||
| Net Income | 10.06 | 14.04 | 4.03 | 4.15 | 0.11 | -3.25 | -5.51 | 7.91 | 6.61 | -19.94 | ||||||||||
| EPS | 1.89 | 2.63 | 0.75 | 0.77 | 0.02 | -0.60 | -1.00 | 1.43 | 1.19 | -3.58 |
QUICKHEAL Company Updates
QUICKHEAL Stock Peers
QUICKHEAL Past Performance & Peer Comparison
QUICKHEAL Past Performance & Peer Comparison
Information TechnologyIT Services & Consulting
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Quick Heal Technologies Ltd | -89.34 | 2.21 | — |
| Tata Consultancy Services Ltd | 16.17 | 7.33 | 5.00% |
| Infosys Ltd | 16.47 | 5.20 | 4.01% |
| HCL Technologies Ltd | 18.77 | 4.48 | 4.69% |
QUICKHEAL Stock Price Comparison
Compare QUICKHEAL with any stock or ETFQUICKHEAL Holdings
QUICKHEAL Shareholdings
QUICKHEAL Promoter Holdings Trend
QUICKHEAL Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
QUICKHEAL Institutional Holdings Trend
QUICKHEAL Institutional Holdings Trend
In last 3 months, retail holding in the company has increased by 1.44%
In last 3 months, foreign institutional holding of the company has almost stayed constant
QUICKHEAL Shareholding Pattern
QUICKHEAL Shareholding Pattern
QUICKHEAL Shareholding History
QUICKHEAL Shareholding History
Mutual Funds Invested in QUICKHEAL
Mutual Funds Invested in QUICKHEAL
No mutual funds holding trends are available
Top 1 Mutual Funds holding Quick Heal Technologies Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0001% | Percentage of the fund’s portfolio invested in the stock 0.00% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 1005/1008 (-6) |
Compare 3-month MF holding change on Screener
smallcases containing QUICKHEAL stock
smallcases containing QUICKHEAL stock
Looks like this stock is not in any smallcase yet.
QUICKHEAL Events
QUICKHEAL Events
QUICKHEAL Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
QUICKHEAL Dividend Trend
No dividend trend available
QUICKHEAL Upcoming Dividends
QUICKHEAL Upcoming Dividends
No upcoming dividends are available
QUICKHEAL Past Dividends
QUICKHEAL Past Dividends
Cash Dividend
Ex DateEx DateAug 30, 2024
Dividend/Share
₹3.00
Ex DateEx Date
Aug 30, 2024
Cash Dividend
Ex DateEx DateJul 28, 2023
Dividend/Share
₹2.50
Ex DateEx Date
Jul 28, 2023
Cash Dividend
Ex DateEx DateAug 18, 2022
Dividend/Share
₹4.50
Ex DateEx Date
Aug 18, 2022
Cash Dividend
Ex DateEx DateJul 29, 2021
Dividend/Share
₹4.00
Ex DateEx Date
Jul 29, 2021
Cash Dividend
Ex DateEx DateMar 2, 2020
Dividend/Share
₹4.00
Ex DateEx Date
Mar 2, 2020
QUICKHEAL Stock News & Opinions
QUICKHEAL Stock News & Opinions
Revenue from operations declined 25.19% year on year (YoY) to Rs 48.73 crore in the quarter ended 31 March 2026. The company reported a loss before tax of Rs 29.67 crore in Q4 FY26, compared with a loss of Rs 6.57 crore in the corresponding quarter last year. EBITDA loss widened to Rs 29.3 crore in Q4 FY26 from Rs 8.5 crore in Q4 FY25, while EBITDA margin deteriorated to a loss of 60.2% from 13% in the year-ago period. Dr. Kailash Katkar, Chairman and Managing Director of Quick Heal Technologies, commented, 'This year has been a mixed one for us. While the consumer vertical faced headwinds due to broader market challenges, our enterprise vertical delivered consistent growth and strong momentum. The industry continues to evolve amid rising geopolitical tensions, an increasingly dynamic AI-driven threat landscape, and changing regulatory environments. At the same time, data privacy regulations have unlocked a significant market opportunity for us. As the industry shifts from reactive to predictive and pre-emptive cybersecurity, we remain committed to transforming ourselves into a full-stack, AI-native, and AI-driven cybersecurity company. Our focused efforts on the enterprise vertical are helping us overcome the challenges faced in the consumer vertical. Based on the progress we are seeing, we believe we should be able to navigate these challenges over the next three to four quarters, with the enterprise business contributing a major share of our revenue.' Ankit Maheshwari, Chief Financial Officer, Quick Heal Technologies, added, 'The enterprise business continued to deliver healthy growth during the year, supported by strong execution and customer traction. Within the Enterprise vertical, we have seen greater success through government and international teams. The consumer business already facing industry headwinds got further impacted due to rising hardware prices. Hence, we have tightened our control on the credit cycles with the partners, thereby impacting the topline. At the same time, costs remained stable, reflecting continued operational discipline. The strategic order announced last year for implementation of Cyber Literacy program was successfully executed, and we secured another significant order for implementation of Integrated Cyber Security Solutions worth 64 Crs during the year. Deferred revenue continued to witness growth, providing improved visibility and confidence in our future performance.' Quick Heal Technologies is a leading global cybersecurity solutions provider. Incorporated in 1995 with a registered office in Pune, it offers end-to-end cybersecurity solutions across B2C, B2B, and B2G segments. With its widely recognized brands 'Quick Heal' and 'Seqrite', the company provides AIpowered, patented technologies that protect endpoints, networks, data, mobility, and cloud environments. Committed to R&D and innovation, Quick Heal Technologies continues to simplify security by delivering best-in-class protection against advanced cyber-threats to millions of customers, enterprises, and government organizations worldwide. Powered by Capital Market - Live
Net Loss of Quick Heal Technologies reported to Rs 19.94 crore in the quarter ended March 2026 as against net loss of Rs 3.25 crore during the previous quarter ended March 2025. Sales declined 25.19% to Rs 48.73 crore in the quarter ended March 2026 as against Rs 65.14 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 10.93 crore in the year ended March 2026 as against net profit of Rs 5.04 crore during the previous year ended March 2025. Sales declined 6.62% to Rs 261.02 crore in the year ended March 2026 as against Rs 279.53 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales48.7365.14 -25 261.02279.53 -7 OPM %-60.17-13.02 --11.25-2.36 - PBDT-25.60-2.94 -771 -6.7413.96 PL PBT-29.67-6.57 -352 -20.641.00 PL NP-19.94-3.25 -514 -10.935.04 PL Powered by Capital Market - Live
Quick Heal Technologies will hold a meeting of the Board of Directors of the Company on 21 May 2026.
Quick Heal Technologies has allotted 18,015 equity shares under ESOP on 27 February 2026. Powered by Capital Market - Live
Quick Heal Technologies has allotted 153 equity shares under ESOP on 30 January 2026. With this allotment, the paid up equity share capital has increased to Rs 54,21,50,750/- divided into 5,42,15,075 Nos. of Equity Share of Rs 10/- each. Powered by Capital Market - Live
Quick Heal Technologies will hold a meeting of the Board of Directors of the Company on 29 January 2026.Powered by Capital Market - Live
Quick Heal Technologies has allotted 15,352 equity shares under ESOP on 24 December 2025. Powered by Capital Market - Live
The company said the engagement is aligned with its ongoing cybersecurity business and supports its strategic objective of delivering comprehensive security solutions to customers. The scope and value of the project mark a key milestone in Quick Heal's continued collaboration with government institutions. According to the company's exchange filing, the contract is valid for five years. Quick Heal also clarified that neither its promoters nor the promoter group has any interest in the awarding authority, and the deal does not fall under related-party transactions as per regulatory guidelines. Quick Heal Technologies is a global cybersecurity solutions provider. It offers end-to-end cybersecurity solutions across B2C, B2B, and B2G segments. Through its flagship brands, Quick Heal and Seqrite, the company delivers AI-powered, patented technologies that safeguard endpoints, networks, data, mobile devices, and cloud environments. The company's consolidated net profit soared 90.6% to Rs 7.91 crore on 13.65% jump in revenue from operations to Rs 83.52 crore in Q2 FY26 over Q2 FY25. Powered by Capital Market - Live
The company said the engagement is aligned with its ongoing cyber security business and supports its strategic objective of delivering comprehensive security solutions to customers. The scope and value of the project mark a key milestone in Quick Heal's continued collaboration with government institutions. According to the company's exchange filing, the contract is valid for five years. Quick Heal also clarified that neither its promoters nor the promoter group has any interest in the awarding authority, and the deal does not fall under related-party transactions as per regulatory guidelines. Quick Heal Technologies is a global cybersecurity solutions provider. It offers end-to-end cybersecurity solutions across B2C, B2B, and B2G segments. Through its flagship brands, Quick Heal and Seqrite, the company delivers AI-powered, patented technologies that safeguard endpoints, networks, data, mobile devices, and cloud environments. The company's consolidated net profit soared 90.6% to Rs 7.91 crore on a 13.65% jump in revenue from operations to Rs 83.52 crore in Q2 FY26 over Q2 FY25. The counter rose 1.82% to settle at Rs 307.50 on the BSE. Powered by Capital Market - Live
Quick Heal Technologies announced that Ajit Zanjad, Vice President Head of Delivery of the Company, has tendered his resignation from the services of the Company for professional growth, with effect from 28 November 2025. Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -1.12%, vs industry avg of 11.06%
Over the last 5 years, market share decreased from 0.06% to 0.04%
Over the last 5 years, net income has grown at a yearly rate of -41.64%, vs industry avg of 9.24%